(Q43872647)

English

In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

Susan L Pendland

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Chad R Messick

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Rose Jung

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

75-78

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the bactericidal activity of ciprofloxacin alone and in combination with selected antipseudomonal beta-lactam agents against clinical isolates of Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900312-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(01)00312-1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43872647&oldid=2105501960"